These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7686288)

  • 1. [Place of G-CSF in allogenic bone marrow grafts].
    Gluckman E
    Pathol Biol (Paris); 1993 Jan; 41(1):51. PubMed ID: 7686288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autologous transplantation of hematopoietic stem cells and growth factors].
    Harousseau JL
    Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation.
    Schwabe M; Hartert AM; Bertz H; Finke J
    Eur J Clin Invest; 2004 Nov; 34(11):759-65. PubMed ID: 15530149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
    Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
    Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow.
    Busch FW; Pilgrim TB; Krämer A; Ehninger G
    Bone Marrow Transplant; 1997 Apr; 19(7):653-9. PubMed ID: 9156241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
    Elfenbein GJ
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of different hematopoietic stem cell sources (primed marrow, mobilized blood, and steady-state marrow) in autologous and allogenic transplantation.
    Chiang KY; Worthington-White D
    Exp Hematol; 2004 Aug; 32(8):698-9. PubMed ID: 15308319
    [No Abstract]   [Full Text] [Related]  

  • 15. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice.
    Koda M; Nishio Y; Kamada T; Someya Y; Okawa A; Mori C; Yoshinaga K; Okada S; Moriya H; Yamazaki M
    Brain Res; 2007 May; 1149():223-31. PubMed ID: 17391650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
    de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
    An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?
    Appelbaum FR
    J Clin Oncol; 2004 Feb; 22(3):390-1. PubMed ID: 14691127
    [No Abstract]   [Full Text] [Related]  

  • 20. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.